By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) To Present At Two Upcoming Investor Conferences 5/23/2016 9:34:23 AM
BioTime (BTX) Reports First Quarter Results And Recent Corporate Accomplishments 5/11/2016 10:29:27 AM
ReCyte Therapeutics, Inc., A BioTime (BTX) Subsidiary, Announces Peer-Reviewed Publication On Pericyte-Like Progenitor Cells 5/6/2016 9:54:02 AM
BioTime (BTX) Co-CEO Dr. Michael West Presents At Biomedical Innovation For Healthy Longevity, International Conference 4/26/2016 12:13:06 PM
BioTime (BTX) Co-CEO Dr. Michael West To Present At Stem Cells In Drug Discovery 2016 In Cambridge, UK 4/5/2016 9:12:40 AM
BioTime (BTX) To Host Conference Call To Update Investors On Recent Accomplishments And Corporate Objectives For 2016 3/21/2016 10:25:16 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Reports The Successful End-Of-Phase II FDA Meeting For Immunotherapy In Acute Myeloid Leukemia 2/24/2016 11:28:10 AM
BioTime (BTX) And Asterias Biotherapeutics Sign Share Transfer Agreement And Cross-License Agreement For Pluripotent Stem Cell Related Patents 2/17/2016 11:32:41 AM
BioTime (BTX) To Present At Three Investor Conferences In February 2/2/2016 11:04:35 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), Announces The Launch Of TGex, The Knowledge-Driven NGS Analysis Platform, Powered By The Genecards Suite 1/20/2016 8:15:46 AM